We are always seeking new partnerships and collaborations for the innovation and development of novel therapeutic approaches with the goal of improving patients’ lives.
We want to align with compatible corporate cultures who, like us, “Follow the Science; Focus on the Patient,” and we seek to establish collaborations that offer mutual incentives and enable synergistic core competencies.
We aim to exploit existing and new viral vectors to make advances based on our clinically validated platform designed to deliver attraction and activation signals to generate tumor-specific immune responses.
We want to collaborate and partner with others to further develop our technology in combination with other traditional or novel therapies or help you systemically deliver your therapeutic to tumors. Collaborations can range from research opportunities, through to pre-clinical studies and clinical trials.
Visit our Contact Us page to start a dialogue on collaborative opportunities.